M&A TRANSACTION · 2019
CardioCel and VascuCel Biologic Patches (Admedus) acquired by LeMaitre Vascular Inc.
$17.4M· 2.50x revenue
Target
CardioCel and VascuCel Biologic Patches (Admedus)
Acquirer
LeMaitre Vascular Inc.
Strategic buyer
Disclosed financials at time of acquisition
Revenue
$7.1M
EBITDA
—
Deal Value
$17.4M
EV/EBITDA
—
Context
This $17.4M acquisition of CardioCel and VascuCel Biologic Patches (Admedus) by LeMaitre Vascular Inc. sits in the medical devices sub-vertical. LeMaitre Vascular Inc. is acquiring as a strategic buyer; see how strategic acquirers typically price medical devices businesses on our Medical Devices strategic buyer-pool page.
Source
Data sourced from SEC filings and press releases. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology
Value your own medical devices
Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.
Compare your business to the CardioCel and VascuCel Biologic Patches (Admedus) acquisition.